The Mission Massimo Foundation aims to exponentially accelerate the discovery of novel genetic variations responsible for childhood Leukodystrophies and to translate these findings into clinical treatments.

Our Prevention Goals

Promote awareness of paediatric white matter disorders and screening options.

Our Diagnosis Goals

Collaborate with researchers to reduce the number of unclassified cases to < 10% before the end of the decade.

Our Treatment Goals

Collaborate with researchers to complete functional studies and generate models of newly identified disorders.

Collaborate with researchers to create vectors capable of delivering corrected genes into target cells.

Collaborate with researchers to develop patient derived stem cell lines to regenerate myelin.

Collaborate with researchers to translate therapies from laboratory to human clinical trials.

Mission Massimo Foundation Inc. Australia

(A.B.N. 21 931 625 405) is registered Health Promotion Charity with the Australian Charities and Not-For-Profits Commission and holds Deductible Gift Recipient status with the Australian Taxation Office.

Mission Massimo Foundation Inc. United States

(E.I.N. 46 3854483) is a Not-For-Profit Public Benefit Corporation registered in the State of California United States and holds 501(c)3 status with the United States Internal Revenue Service.